Latest headlines
AbbVie News
The latest AbbVie (ABBV) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these ABBV headlines next to the live AbbVie Fear and Greed Index.
Latest AbbVie Headlines60
AbbVie Inc (ABBV) Stock Down 0.7% but Still Overvalued -- GF Score: 76/100
gurufocus.com · Jul 10, 2026
Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner
247wallst.com · Jul 10, 2026
AbbVie (ABBV) Stock Drops Despite Market Gains: Important Facts to Note
zacks.com · Jul 9, 2026
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth
zacks.com · Jul 9, 2026
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
fool.com · Jul 9, 2026
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma
zacks.com · Jul 7, 2026
Buy these quality, low-stress stocks for the summer, says Jefferies
cnbc.com · Jul 7, 2026
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
fool.com · Jul 7, 2026
3 Dividend Aristocrats to Buy in July
247wallst.com · Jul 7, 2026
The Dividend ETF Quietly Outperforming the S&P 500
fool.com · Jul 7, 2026
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
prnewswire.com · Jul 6, 2026
Will Immunology Franchise Aid AbbVie's Upcoming Q2 Results?
zacks.com · Jul 6, 2026
Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It.
247wallst.com · Jul 3, 2026
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
fool.com · Jul 3, 2026
J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?
zacks.com · Jul 2, 2026
3 Dividend Stocks to Buy Hand Over Fist in July
247wallst.com · Jul 2, 2026
AbbVie: Apogee Deal Just Widened An Already Dominant Moat
seekingalpha.com · Jul 2, 2026
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
fool.com · Jun 30, 2026
What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?
zacks.com · Jun 30, 2026
Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunity
benzinga.com · Jun 30, 2026
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jun 30, 2026
Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
prnewswire.com · Jun 29, 2026
ABBV Gets CHMP Nod for Rinvoq in Two Different Autoimmune Diseases
zacks.com · Jun 29, 2026
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
zacks.com · Jun 29, 2026
3 No-Brainer Dividend Stocks to Buy Right Now
fool.com · Jun 29, 2026
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
fool.com · Jun 29, 2026
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
zacks.com · Jun 29, 2026
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
gurufocus.com · Jun 29, 2026
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
prnewswire.com · Jun 29, 2026
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
prnewswire.com · Jun 29, 2026
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
prnewswire.com · Jun 26, 2026
Lilly, J&J and AbbVie Hit New Highs
gurufocus.com · Jun 26, 2026
AbbVie to Host Second-Quarter 2026 Earnings Conference Call
prnewswire.com · Jun 26, 2026
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
fool.com · Jun 25, 2026
Is AbbVie a Buy After Its Purchase of Apogee?
fool.com · Jun 25, 2026
3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree
247wallst.com · Jun 25, 2026
Why I Can't Stop Buying This Unstoppable Dividend Juggernaut
247wallst.com · Jun 24, 2026
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
gurufocus.com · Jun 24, 2026
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
businesswire.com · Jun 24, 2026
AbbVie's $11 Billion Immunology Bet
forbes.com · Jun 24, 2026
AbbVie Gets EU Nod for Skyrizi in Pediatric Plaque Psoriasis
zacks.com · Jun 24, 2026
64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital
247wallst.com · Jun 24, 2026
BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026
prnewswire.com · Jun 24, 2026
After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching
247wallst.com · Jun 24, 2026
AbbVie's Costly Apogee Acquisition Has Long-Term Upside: Analyst
benzinga.com · Jun 23, 2026
ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout
zacks.com · Jun 23, 2026
Nova Minerals redomiciles to US as Alaska gold and antimony work accelerates
proactiveinvestors.com · Jun 23, 2026
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
prnewswire.com · Jun 23, 2026
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
247wallst.com · Jun 23, 2026
G50 Corp strikes high-grade gold at first White Caps core hole in Nevada
proactiveinvestors.com · Jun 23, 2026
3 Monster Stocks to Hold for the Next 10 Years
fool.com · Jun 23, 2026
AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
prnewswire.com · Jun 23, 2026
Empire Metals to host investor presentation on Pitfield progress
proactiveinvestors.com · Jun 23, 2026
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
gurufocus.com · Jun 23, 2026
Metals One builds 5.57% stake in newly listed Talon Resources
proactiveinvestors.com · Jun 23, 2026
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
prnewswire.com · Jun 23, 2026
Why AbbVie Stock Jumped Today
fool.com · Jun 22, 2026
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?
fool.com · Jun 22, 2026
Why Is AbbVie Up or Down Today?
When AbbVie (ABBV) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a ABBV move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AbbVie is up or down today.
How AbbVie News Affects the Price
News does not move the AbbVie (ABBV) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AbbVie Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AbbVie trading volume. That is the chain to watch: headline, sentiment, volume, then the ABBV price.
Trade the AbbVie News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AbbVie trading volume spike on a big story, check the AbbVie price history for context, follow the live ABBV price, see the AbbVie price prediction, and read the AbbVie Fear and Greed Index for mood.
How do you feel about AbbVie?
1DFrequently asked questions
Why is AbbVie up or down today?
What is the latest AbbVie news?
Where does AbbVie news come from?
How often is AbbVie news updated?
How does AbbVie news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and more than 100 individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.